复合抗原多肽及其在血吸虫病疫苗中的研究进展
RECENT ADVANCES IN MULTIPLE ANTIGEN PEPTIDES TO SCHISTOSOMIASIS VACCINE
出处
《中国血吸虫病防治杂志》
CAS
CSCD
2002年第5期390-392,共3页
Chinese Journal of Schistosomiasis Control
参考文献17
-
1[1]Zheng W, Ghosh S, Mscris M, et al. Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes:influence if different chemical linkages and epoitope orientations on biological activity [J]. Vaccine, 2001, 19(28-29): 3843-3852.
-
2[2]Tam JP. Synthetic peptide vaccine design: Synthesis and properties-density multiple antigenic peptide system[J]. Proc Natl Acad Sci USA, 1998, 85(15): 5409-5413.
-
3[3]Tam JP. Recent advances in multiple antigen peptides[J]. J Immnuol Met, 1996, 196(1): 17-23.
-
4[4]Tam JP, Zavala F.Multiple antigen peptide:A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays[J]. J Immunol Met, 1989, 124(1): 53-61.
-
5[5]Chargelegue D, Obeid OE, Shaw DM, et al. Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein[J]. Immunology Letters, 1997, 57(1-3): 15-17.
-
6[6]Tam JP, Lu YA. Vaccine engineering: Enhancement of immunogenicity of synthetic peptide vacines related to hepatitis in chemically defined models consisting of T-and B-cell epitopes[J]. Proc Natl Acad Sci USA, 1989, 86(23): 9084-9088.
-
7[7]Defoort JP. Nardelli B, Huang W, et al. A rational design of synthetic peptide vaccine with a built-inadjuvant. A modular approach for unambiguity[J]. Int J Pept Protein Res, 1992, 40(3-4): 214-218.
-
8[8]Defoort JP, Nardelli B, Huang W, et al. Macromolecular assemblage in the design of a synthetic AIDS vaccine [J]. Proc Natl Acad Sci USA, 1992, 89(9): 3879-3883.
-
9[9]Reynolds SR, Dahi CE, Harn DA, et al.T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triode phosphate isomerase[J]. J Immunol, 1994, 152(1): 193-200.
-
10[10]Bergquist NR, Colley DG. Schistosomiasis vaccine:Research to development[J]. Parasit Today,1998,14(3): 99-104.
-
1陈家旭.研制血吸虫病疫苗的不同途径[J].国外医学（寄生虫病分册）,2000,27(1):25-26. 被引量：3
-
2Capron A,陶伊文.血吸虫病疫苗对策[J].国外医学（寄生虫病分册）,1992,19(5):203-206. 被引量：1
-
3辛晓芳,朱荫昌,王国治.日本血吸虫病疫苗研究进展[J].中国血吸虫病防治杂志,2006,18(5):397-400. 被引量：1
-
4许家喜.血吸虫病合成多肽疫苗[J].中国寄生虫病防治杂志,1997,10(3):227-229. 被引量：5
-
5宋海林,揭盛华,陈应文.血吸虫病疫苗研究进展[J].医药导报,2000,19(2):117-118. 被引量：1
-
6李文桂,陈雅棠.血吸虫病DNA疫苗研究进展[J].中国血吸虫病防治杂志,2003,15(1):75-79. 被引量：1
-
7陈仕荣,王昌才,钟雄林,胡亚芳,王启松.恶性疟合成多肽抗原基因在大肠杆菌中表达产物的分离纯化[J].生物工程学报,1995,11(2):196-199. 被引量：1
-
8阮志燕,吴忠道.血吸虫疫苗研制的进展和前景[J].中国热带医学,2002,2(1):64-65.
-
9新型人工合成肽:水蛭素类似物—降钙素基因相关肽嵌合体的抗凝活性[J].岭南心血管病杂志,2000,6(4).
-
10石佑恩.血吸虫病疫苗与血吸虫病预防[J].中国实用内科杂志,1998,18(3):175-177. 被引量：2
